Cyrusone Inc (CONE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | ||
| Net Income | 1,500 | 3,500 |
| Depreciation Amortization | 55,500 | 36,200 |
| Income taxes - deferred | 1,600 | 2,400 |
| Accounts receivable | -3,300 | -4,300 |
| Other Working Capital | 2,500 | -1,300 |
| Other Operating Activity | 8,200 | 7,000 |
| Operating Cash Flow | $66,000 | $43,500 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -117,500 | -29,300 |
| Other Investing Activity | 11,700 | -11,200 |
| Investing Cash Flow | $-105,800 | $-40,500 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 66,600 | 15,500 |
| Debt Repayment | -23,200 | -10,200 |
| Other Financing Activity | -7,900 | -3,400 |
| Financing Cash Flow | $35,500 | $1,900 |
| Beginning Cash Position | 4,900 | N/A |
| End Cash Position | 600 | 4,900 |
| Net Cash Flow | $-4,300 | $4,900 |
| Free Cash Flow | ||
| Operating Cash Flow | 66,000 | 43,500 |
| Capital Expenditure | -117,500 | -29,300 |
| Free Cash Flow | -51,500 | 14,200 |